DAT – direct astigmatic test

There are 7.2 billion people on our planet. Each of us needs to protect his eyes. And with 4.5 billion of us requiring visual correction to see well, poor vision is the world’s most widespread disability. Our mission is to globalize state-of-the-art DAT technology in order to improve lives by improving sight.

Independent R&D proved that DAT technology allows not only detection and accurate correction of astigmatism but also:
• glaucoma and localization of its outbreaks
• cataracts and its location
• corneal changes
• hanges in the vitreous body
• children’s narrowing of the optic nerve
• diagnosis of the entire visual path

DAT technology enables also “fast track”:
• diagnosis of diabetes
• diagnosis of the pancreas
• neurooptics
• supporting retinal electrophysiological examination (VEP-DAT)
• neurosurgery of the conscious patient
• functional micro-impact diagnostics
• percussive diagnosis of the “golden hour”
• toxicology and drug testing

ADVANTAGES:
• possibility of diagnostics among small children, people with autism, deaf and mild disabilities
• fast eye screening diagnostics
• rapid field-of-view diagnostics
• no need to administer drugs (poisons) that paralyze accommodation,
• no risk of any complications after the test
• the test does not burden the patient, it can be repeated often to illustrate changes in the type of stroke or the response to anticoagulants
• examination without physical contact with the patient – hygienic aspect
• possible to use in medical telediagnostics
• possibility of group research

Company’s Keywords: